baber/WOPTO huggingface dataset:
Patent AT-E550298-T1 (AT)
Inventor: PERSSON MICHAEL
IPC: C01B33/152
Filed: 1998-06-08
Granted: 2012-04-15
Abstract: The present invention relates to polysilicate microgels, their preparation and use in paper making and water purification, the polysilicate microgels being obtainable by a process which comprises bringing into contact (i) particles of a salt AB with an aqueous silicate or polysilicate solution, (ii) an ion A with an ion B in the presence of an aqueous silicate or polysilicate solution, whereby the salt AB is precipitating in the aqueous phase, or (iii) an ion A with an ion B in the presence of an aqueous silicate or polysilicate solution, whereby the ions A and B represent ions of a precipitable salt AB having a pKS value of at least 4, measured at 20° C. in water. The invention further relates to aqueous silicate or polysilicate solutions, their preparation and use as precursors for polysilicate microgels. The aqueous silicate or polysilicate solutions contain an ion A which is calcium or magnesium, wherein the molar ratio of SiO2:A is less than 2000:1 and higher than 1:1, or an ion B which is carbonate, sulfate or phosphate, wherein the molar ratio of SiO2:B is less than 2000:1 and higher than 1:1.
Patent AT-E377022-T1 (AT)
Inventor: VALMORI DANILA
IPC: A61K39/00
Filed: 1998-06-18
Granted: 2007-11-15
Abstract: A method for inducing proliferation of cytolytic T cells is described.
Patent AT-E305048-T1 (AT)
Inventor: GLADUE RAYMOND M
IPC: A23D9/007
Filed: 1998-07-31
Granted: 2005-10-15
Abstract: This invention provides a particulate material suitable for use as a nutritional supplement, particularly as an aquaculture feed. The particulate material has a high proportion of DHA residues in the lipid fraction, which may be up to 35% of the material, or even more. Preferably, the material has a mean particle size of from about 5 microns to about 10 microns. This invention also provides a method for preparing a particulate material suitable for use as an aquaculture feed from microbial biomass, preferably from algal cells having a high content of DHA residues, by obtaining a lipid fraction from the biomass, preferably by solvent extraction of broken cells, followed by separating a fraction containing phospholipids and proteins from the lipid fraction, and removing water from the protein/phospholipid fraction to form a low moisture particulate, preferably by spray-drying the protein/phospholipid fraction.
Patent AT-E238544-T1 (AT)
Inventor: KELSON ITZHAK
IPC: G01N23/221
Filed: 1998-08-19
Granted: 2003-05-15
Abstract: An apparatus and method for using alpha-particle energy loss to measure the thickness and stoichiometry of films grown by molecular beam epitaxy and other methods. The apparatus for measuring the thickness of films grown on a substrate in a growth chamber, comprises a protective housing having an aperture opening into the growth chamber, a solid state detector disposed in the protective housing, a shutter for opening and closing the aperture, a shield disposed in the housing between the aperture and the solid state detector for shielding the detector, and a calibration source disposed between the shield and the detector for calibrating the measurements made by the detector. A second calibration source disposed between the shutter and the shield, for measuring deposition on the shield.
Patent AT-E217194-T1 (AT)
Inventor: KOOISTRA TEAKE
IPC: A61K45/00
Filed: 1998-10-15
Granted: 2002-05-15
Abstract: To reduce or prevent adhesions to or between organs, parts of organs or tissues, at a particular location in a mammal, the invention proposes to subject the mammal to a treatment which provides for reduced internalization and degradation of plasminogen activators in mesothelial cells present at the location. In particular, the mammal is treated locally with an active agent capable of interfering with internalization of plasminogen activators by their receptors on mesothelial cells, or interfering with recycling of these receptors, or blocking these receptors to prevent binding of plasminogen activators, or interfering with degradation of plasminogen activators in mesothelial cells. Examples of such active agents are chloroquine and 39 kd receptor-associated protein. Alternatively, expression of said receptors by the mesothelial cells is downregulated, or the mammal is treated with a plasminogen activator mutant which resists receptor-mediated endocytosis.
Patent AT-E298558-T1 (AT)
Inventor: KONIK RICHARD A
IPC: A61K8/00
Filed: 1998-10-29
Granted: 2005-07-15
Abstract: The invention relates to transfer-resistant color cosmetic compositions comprising a film forming agent, a volatile oil, a styrene-ethylene-propylene copolymer as gellant, and optionally, a pigment.
Patent AT-E234067-T1 (AT)
Inventor: BANOWSKI BERNHARD
IPC: A45D40/20
Filed: 1998-10-30
Granted: 2003-03-15
Abstract: An improved stick preparation is provided which is made up of at least two separate phases and at least one phase contains spherical polymer particles which can contain a pigment. The particles provide smoothness to the preparation and can be used to provide an interesting visual appearance to the stick.
Patent AT-E239439-T1 (AT)
Inventor: WITOWSKI NORBERT
IPC: A61J1/00
Filed: 1998-11-16
Granted: 2003-05-15
Abstract: The invention relates to a tank (100) used to administer flowable substances, characterised in that (a) the tank (100) has flexible walls (2 & 3); (b) the walls of the tank are single-pieced or joined to each other; (c) the walls (2 & 3) of the tank form a closed container having at least one opening; (d) the walls of the tank (2 & 3) are partially joined to at least two flat vertical elements (6) which are separated from the walls of the of the tank in the fixed area of said walls (2 & 3); and (e) the opening (12) has one closure (13). At least parts of the walls of the tank (2 & 3) and/or vertical elements (6) are made of composite material and consist of (i) plastic laminate or (ii) at least one plastic laminate and an aluminium laminate whereby said laminates are joined to each other. Preferably, the tank is designed to receive contrast agents.
Patent AT-E250153-T1 (AT)
Inventor: JURMANN ALEXANDER DIPL-ING
IPC: C23C8/20
Filed: 1999-04-23
Granted: 2003-10-15
Abstract: The atmosphere used in carburisation of workpieces is based on ethanol and carbon dioxide. Enrichment and depletion of the atmosphere is produced by the corresponding adjustment of the stoichiometric ratio of ethanol and carbon dioxide. An Independent claim is also included for a carburisation apparatus comprising an ethanol source (A) and a carbon dioxide source (C) connected together. A measuring device (M) is also present to measure the carbon level in the furnace.
Patent AT-E288142-T1 (AT)
Inventor: SCHAUT DIETHARD
IPC: H01R39/40
Filed: 1999-07-20
Granted: 2005-02-15
Abstract: A square-shaped casing takes a carbon brush pushed in and has an opening (16) on its face side for passing the carbon brush through. A spring (41) fitted in the casing acts upon the carbon brush and is restrained by a device on the side of the casing. A second restrainer (48,50) runs towards the rear side of the casing to operate with the spring.
Patent AT-E235376-T1 (AT)
Inventor: HIRABAYASHI HIROMITSU
IPC: B41J2/05
Filed: 1992-07-29
Granted: 2003-04-15
Abstract: An ink jet recording apparatus for performing recording using a recording head for ejecting an ink from a plurality of ejection orifices, includes a print control unit for performing a print operation while switching a print mode between a thin multi-pass print mode for sequentially recording divided recording data in a plurality of number of times of relative scan operations of the recording head with respect to a single recording area, and a 1-pass print mode for recording all recording data in a single relative scan operation of the recording head, and an eject quantity control unit for controlling the eject quantity of the ink ejected from the recording head so that a total ink quantity on the recording area in the thin multi-pass print mode is larger than a total ink quantity in the 1-pass print mode. <IMAGE>
Patent AT-E226893-T1 (AT)
Inventor: HASENOEHRL KARL
IPC: B41J2/32
Filed: 1999-02-04
Granted: 2002-11-15
Abstract: The invention relates to a thermoprinter (10) with at least one thermoprinting head (22, 32, 42) and a printing roller (24, 34, 44). The invention additionally provides that the thermoprinting head (22, 32, 42) and the printing roller (24, 34, 44) are combined to form a printing unit (20, 30, 40) by means of a mounting device (26). The printing unit is arranged on the thermoprinter (10) in such a way that it can be replaced.
Patent AT-E401828-T1 (AT)
Inventor: EGAN THOMAS
IPC: A61B17/56
Filed: 1999-04-13
Granted: 2008-08-15
Abstract: A suture guide and fastener includes a suture retaining device which orients and secures one or more suture strands therein and receives energy applied to the strands to bond them within the suture retaining device. The fastener becomes integral with the bonded sutures and may be made of a material similar to the suture material, which melts upon the application of energy thereto. Alternatively, the fastener may be made of a different material which remains intact upon application of bonding energy to the sutures. When ultrasonic energy is applied, the fastener may function as a stationary ultrasonic weld anvil. Other types of energy, such as laser, thermal or chemical, may be applied to the suture strands to effect bonding.
Patent AT-E374738-T1 (AT)
Inventor: TAKAHASHI KAZUHIRO
IPC: B01J27/12
Filed: 1999-07-16
Granted: 2007-10-15
Abstract: Fluorochromium oxide having a fluorine content of not less than 30 wt.% is used for the fluorination reaction. To provide a manufacturing method for fluorine-containing ethane which contains 1, 1, 1, 2, 2-pentafluoroethane as the main component in which the reaction can be performed while controlling the generation of CFCs to the greatest possible extent by fluorinating at least one selected from the group composed of tetrachloroethylene, 2, 2-dichloro-1, 1, 1-trifluoroethane and 2-chloro-1, 1, 1, 2-tetrafluoroethane with hydrogen fluoride.
Patent AT-E250332-T1 (AT)
Inventor: KANANEN DAVID L
IPC: A01G1/04
Filed: 1999-02-22
Granted: 2003-10-15
Abstract: A mushroom spawn comprising a mixture of: (a) at least one proteinaceous ingredient in an amount to provide at least 3.5% nitrogen on a dry weight basis; (b) 2 to 30 wt % based on dry weight of paper pellets (c) 5 to 60 wt % based on dry weight of at least one particulate material, (d) a buffer in an amount effective to provide a pH of about 6 to 7.8, and (e) water; and colonized with mushroom mycelium wherein the (b) paper pellets, (c) particulate material, or both in an amount effective to provide at least 10,000 particles per 100 g of finished product.
Patent AT-E408339-T1 (AT)
Inventor: MACDONALD DAVID DUNCAN
IPC: A01K13/00
Filed: 1999-09-23
Granted: 2008-10-15
Abstract: An equine multi-purpose protector boot comprising: (a) a sole member rigid enough to resist lateral movement of the hoof with an upwardly depending rim extending around its periphery at least at the toe and at each side, the inner surface of the rim being substantially vertical at least in the region of the sides: (b) at least one flexible side flap located at each side of the hoof, attached to or integral with the sole member; (c) an outer compressive cover provided with means to force the side flap into conformation with the shape of the hoof; (d) a flexible heel member attached to the rear of the sole member and including at least one fastening strap (16) adapted to pass around the pastern bone within the range of 2 to 3.5 cm above the coronary band.
Patent AT-E275358-T1 (AT)
Inventor: SOERBOE LARS
IPC: A47C27/12
Filed: 1999-10-06
Granted: 2004-09-15
Abstract: A sitting, sleeping or support pad (1), which on account of its special design can be used in a number of different areas of application, includes an inner bag with a fill material, disposed in an outer bag. The inner bag has an elongated, substantially rectangular shape and the outer bag consists of first and second sides (2, 3), with a I substantially similar shape to the inner bag, where between the outer bag's first and second sides (2, 3), at least in a part of the bag's length against one of the short sides of the outer bag, there is provided an intermediate piece (6) and an end portion (4) is formed on at least one short side. The end portion (4) is enlarged and provides the opportunity for the pad to be placed on the short side, as well as for all or most of the fill material to be collected in a part of the inner bag, thereby to provide co-operation between inner bag and outer bag to achieve a sitting position where the user is raised above ground level.
Patent AT-E239748-T1 (AT)
Inventor: FAGAN PAUL J
IPC: C07F15/00
Filed: 1999-10-13
Granted: 2003-05-15
Abstract: Novel reactions used to prepare phosphole and bisphosphole compounds are detailed. Novel phosphole compounds and metal coordination compounds of phosphole and bisphosphole compounds are also provided. These metal coordination compounds are useful as catalysts for the polymerization or olefins with carbon monoxide and for the polymerization of acrylic monomers.
Patent DE-9804544-T1 (DE)
Title: Anlage zum beladen von schachtöfen sowie unterseitendichtungsventilanordnung dafür
IPC: C21B7/20
Filed: 2009-07-30
Abstract: Beschickungsvorrichtung für einen Schachtofen, insbesondere für einen Hochofen, wobei die Vorrichtung Folgendes umfasst: mindestens zwei Bunker zur Zwischenlagerung von in den Ofen zu chargierendem Beschickungsmaterial, und eine untere Dichtventilbaugruppe umfassend ein unteres Dichtventilgehäuse, das unter den Bunkern angeordnet ist und Folgendes aufweist: mindestens zwei Einlässe, wobei jeder Einlass einen jeweiligen zugeordneten Ventilsitz aufweist und jeder Einlass jeweils mit einem der Bunker in Verbindung steht, und einen Auslass zum Leiten von Beschickungsmaterial in den Ofen; und einen Dichtventilmechanismus zum Abdichten der Einlässe; dadurch gekennzeichnet, dass der Dichtventilmechanismus einen einseitigen Verschluss mit einer einzigen Dichtfläche umfasst, wobei der Dichtventilmechanismus derart konfiguriert ist, dass er die Dichtfläche des einseitigen Verschlusses abwechselnd in Dichtkontakt mit jedem der mindestens zwei Ventilsitze bringt, um den zugeordneten Einlass abzudichten.
Patent DE-20164728-T1 (DE)
Title: Impfstoffe gegen atemwegsvirus
Inventor: CIARAMELLA GIUSEPPE
IPC: A61K39/12
Filed: 2016-10-21
Abstract: Betacoronavirus(BetaCoV)-Impfstoff, umfassend mindestens ein Ribonukleinsäure(RNA)-Polynukleotid, das einen offenen Leserahmen aufweist, der für mindestens ein antigenes BetaCoV-Polypeptid codiert; wobei das mindestens eine antigene BetaCoV-Polypeptid (a) ein Spike(S)-Protein oder ein immunogenes Fragment davon oder (b) eine S1-Untereinheit oder eine S2-Untereinheit des S-Proteins oder ein immunogenes Fragment davon ist; und wobei der BetaCoV-Impfstoff in einem Lipid-Nanopartikel formuliert ist.
Patent DE-20196219-T1 (DE)
Title: Glypican-3-Spezifische Chimäre Antigenrezeptoren für adoptive Immuntherapie
Inventor: HECZEY ANDRAS
IPC: A61K35/17
Filed: 2015-09-25
Abstract: T-Zellen, die einen chimären Antigen-Rezeptor (CAR) exprimieren, der auf Glypican-3 (GPC3) abzielt, zur Verwendung in einem Verfahren zur Behandlung einer Krankheit, welche mit der Proliferation und/oder Aktivität von GPC3-positiven Zellen in einem Individuum assoziiert ist, wobei das Verfahren den Schritt des Inkontaktbringens der Zellen mit einer therapeutisch wirksamen Menge der T-Zellen umfasst, und wobei der CAR (i) einen scFv-Antikörper, bei dem es nicht um 3E11, 2G9, 4G5, 3D8 oder 2E10 handelt, und (ii) eine kostimulatorische CD28-Domäne umfasst, wobei:(a) die T-Zellen ein Polynukleotid beherbergen, welches den CAR kodiert und SEQ ID NO: 19, SEQ ID NO: 33, SEQ ID NO: 12 oder SEQ ID NO: 29, oder eine Kombination davon umfasst; und/oder(b) der CAR die Aminosäuresequenz von SEQ ID NO: 18, SEQ ID NO: 32, SEQ ID NO: 10 oder SEQ ID NO: 28, oder eine Kombination davon umfasst; wobei es sich bei der Krankheit um Krebs oder das Simpson-Golabi-Behmel-Syndrom handelt.
Patent DE-203898-T1 (DE)
IPC: B65G17/32
Filed: 1986-04-30
Abstract: A conveyor line with pallets for conveying heavy loads has a guide member (3) with a U-shaped cross section in which there runs a conveyor belt (2), which can be guided rectilinearly or in curves and comprises links of glidable material. Pallets (6) carrying objects are conveyed along the line. The pallets have two guide segments (11) swivelable about vertical axes (x-x) in tandem in the conveying direction and via support rollers (8) said segments bear against separate support members (7), one on either side of the guide member (3). The guide segments have glide shoes (20) mounted coaxially with the axes (x-x) for yieldingly engaging against the belt (2) so that the pallet accompanies the belt in its movement. The segments have guide rollers (30) following opposing, parallel walls (4,4) of the U section guide member for positioning the guide segments along the straight and curved portions of the line. The belt is not loaded by the weight of the conveyed load and only by suited compression force from the guide shoe allowing the pallet to be kept stationary while gliding against the belt without the belt being subjected to excessive tensional load due to large friction forces.
Patent DE-320519-T1 (DE)
IPC: A61K31/785
Filed: 1987-12-14
Abstract: Orally ingestible compositions for reduction of blood cholesterol levels comprising cholestyramine and as deodorant material a water-soluble carbohydrate syrup such as high fructose corn syrup or a liquid alcohol polyol humectant such as glycerine. The components are blended to form a deodorized powder which may be added to water to form a beverage or mixed with an additional carbohydrate material such as polydextrose to form a unitary orally ingestible product such as a wafer.
Patent DE-461191-T1 (DE)
Inventor: LEBESCH D
IPC: G01R31/72
Filed: 1990-02-26
Abstract: Method and apparatus for automatically testing an electrical coil through a surge tester. Comparison to a stored waveform through error area ratio computation is achieved by use of digital computer data processing techniques. A uniform threshold of acceptability is disclosed which is not dependent on voltage or type of coil tested. Statistical analysis may be programmed or hardwired into an embodiment to yield easily discernable manufacturing or field test information. Optimization of the entire process and the testing steps may also be achieved through an apparatus which may provide a variety of different output possibilities and which may be customized to the user's situation. Update and storage of test results is included as well as correlation with manufacturing data.
Patent DE-934999-T1 (DE)
Inventor: STEMMER WILLEM P C
IPC: C12Q1/6811
Filed: 1995-02-17
Abstract: The present invention provides a population of polynucleotides resulting from shuffling sequences from substrate polynucleotides encoding antibody chains, whereby the population of polynucleotides comprises recombinant polynucleotides encoding antibody chains having different combinations of heavy chain CDRs and/or light chain CDRs than are encoded by the substrate polynucleotides. Such a population of polynucleotides may be employed to provide an antibody display library.
Patent ES-2189706-T1 (ES)
Title: Chasis fijo de soporte de un recinto rotativo tal como una mantequera.
Inventor: JAGOREL LOIC
IPC: B01F29/60
Filed: 2002-07-26
Abstract: Chasis fijo de soporte de un recinto rotativo tal como una mantequera, equipado con órganos de accionamiento y de control, unidos por cables y canalizaciones, caracterizado porque dicho chasis (20) está constituido por una estructura tubular (21, 22, 23), en la que al menos uno de los tubos (21) es apropiado para constituir un paso para dichos cables.
Patent CY-1108190-T1 (CY)
Title: Ανασυνδυασμενος υποδοχεας κολλαγονου αιμοπεταλιων της γλυκοπρωτεϊνης vi και η φαρμακευτικη του χρηση
Inventor: CLEMETSON KENNETH J
IPC: C12N15/09
Filed: 2008-07-11
Abstract: Η εφεύρεση αναφέρεται στην Γλυκοπρωτεΐνη VI (GPVI), στην απομόνωσή της, τον καθαρισμό της, και σε μεθόδους για ανασυνδυασμένη παραγωγή αυτής. Ειδικότερα, η εφεύρεση αναφέρεται στην χρήση της GPVI, κατά προτίμηση της ανασυνδυασμένης GPVI, στην θεραπεία των διαταραχών και των παθολογικών καταστάσεων που σχετίζονται άμεσα ή έμμεσα με τις διαταραχές κατά την πήξη του αίματος, όπως είναι τα θρομβωτικά και τα καρδιαγγειακά νοσήματα. Η εξωκυτταρική ανασυνδυασμένη πρωτεΐνη μπορεί επίσης να χρησιμοποιηθεί για τη διενέργεια προσδιορισμών ελέγχου προκειμένου να βρεθούν πιθανοί αναστολείς της GPVI που είναι προσκολλημένη στη μεμβράνη, προκειμένου να ανασταλεί η πρόσδεση των θρομβοκυττάρων και των αιμοπεταλίων, αντίστοιχα, στο κολλαγόνο. Οι αλλαγές στην GPVI μπορούν να χρησιμοποιηθούν για την παρακολούθηση της ηλικίας των αιμοπεταλίων και της έκθεσης σε θρομβωτικά και καρδιαγγειακά νοσήματα.
Patent CY-1109460-T1 (CY)
Inventor: FRANK ROBERT
IPC: C07D471/04
Filed: 2009-09-30
Abstract: Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds corresponding to formula I, methods for the preparation thereof, pharmaceutical compositions containing said compounds, the use of said compounds for preparing pharmaceutical compositions and related treatment methods.
Patent CY-1112200-T1 (CY)
Title: Συνδυασμοι για τη θεραπεια ασθενειων που ενεχουν κυτταρικο πολλαπλασιασμο
Inventor: MUNZERT GERD
IPC: A61K31/519
Filed: 2011-09-13
Abstract: Η παρούσα εφεύρεση σχετίζεται με μια φαρμακευτική σύνθεση για τη θεραπεία ασθενειών που ενέχουν κυτταρικό πολλαπλασιασμό. Η εφεύρεση επίσης σχετίζεται με μια μέθοδο για τη θεραπεία των αναφερόμενων ασθενειών, που περιλαμβάνει συνχορήγηση μιας ένωσης 1 του Τύπου (I) όπου οι ομάδες L, R1, R2, R3, R4 και R5 έχουν τις έννοιες που δόθηκαν στις αξιώσεις και την περιγραφή, προαιρετικώς στη μορφή των ταυτομερών, ρακεμικών μιγμάτων, εναντιομερών, διαστερεομερών της και μιγμάτων αυτών και προαιρετικώς στη μορφή των φαρμακολογικώς αποδεκτών αλάτων προσθήκης οξέος, ενδιαλυτωμένων μορφών, ενυδατωμένων μορφών, πολυμορφικών μορφών, φυσιολογικώς λειτουργικών παραγώγων ή προφαρμάκων αυτής, και μιας αποτελεσματικής ποσότητας μιας δραστικής ένωσης 2 και/ή συνθεραπεία με ραδιοθεραπεία, σε αναλογία που προσφέρει προσθετική και συνεργιστική επίδραση, και με τη συνδυασμένη χρήση μιας ένωσης 1 του Τύπου (I) και μιας αποτελεσματικής ποσότητας μιας δραστικής ένωσης 2 και/ή ραδιοθεραπείας για την παρασκευή των αντίστοιχων φαρμακευτικών παρασκευασμάτων συνδυασμού.
Patent CY-1113034-T1 (CY)
Title: Πανελ δαπεδου ή πανελ τοιχου
Inventor: OLOFSSON OLA
IPC: E04F15/04
Filed: 2012-03-22
Abstract: Ένα πάνελ δαπέδου ή πάνελ τοίχου (20) είναι εξοπλισμένο με μία γλώσσα (1) και μία αύλακα (2), όπου έκαστη περιλαμβάνει συνεργαζόμενα μέσα κλειδώματος υπό τη μορφή νευρώσεων (11, 12) και αυλάκων (9, 10). Τα μέσα κλειδώματος της άνω πλευράς και της κάτω πλευράς της γλώσσας (1) και αύλακας (2) αντίστοιχα είναι διατεταγμένα υπό μετάθεση και υπό μία κατεύθυνση εισαγωγής, κατά την οποία τα δύο πάνελ που πρόκειται να συνδεθούν μεταξύ τους είναι συνδεδεμένα, ώστε να σχηματίσουν μία σφιχτή σύνδεση μεταξύ δύο γειτονικών πάνελ, εις την οποία μία πρόσθετη βαθμίδα (31) επιφανειακού τμήματος (31, 32, 51) είναι διατεταγμένη επί της επιφανειακής περιοχής της άνω πλευράς (3), η οποία είναι εστραμμένη προς την αύλακα (2) και/ή της κάτω πλευράς (5) της αύλακας, η οποία σχηματίζεται ως μία βαθμίδα (31) ή λοξοτομή (32, 51).
Patent CY-1113508-T1 (CY)
Title: Παραγωγα 2,4-διαμινοπυριμιδινης
Inventor: BAENTELI ROLF
IPC: A61P13/12
Filed: 2012-12-19
Abstract: Παρέχονται ενώσεις του χημικού τύπου (I), όπου οι Χ, R1, R2, R3, R4, R5, R6, R7, R8 και R9 έχουν οριστεί στην αξίωση 1, οι οποίες μπορούν να χρησιμοποιηθούν στις διαταραχές στις οποίες η αναστολή της ΖΑΡ-70 και/ή Syk παίζει ρόλο ή προκαλείται από τη δυσλειτουργία των καταρρακτών σηματοδότησης που συνδέονται με την FAK.